110 results on '"Soriano, Vicente"'
Search Results
2. The incidence of HIV-2 infection in Spain is declining – a registry data analysis
3. Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta-analysis
4. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain
5. Screening for HTLV-1 infection should be expanded in Europe
6. HTLV-1-associated myelopathy in Spain
7. Triple Threat: HDV, HBV, HIV Coinfection
8. Genetic signature detected in T cell receptors from patients with severe COVID-19
9. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
10. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain
11. Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection
12. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study
13. Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
14. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies
15. The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America
16. Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
17. Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain
18. Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation
19. Coronavirus and other airborne agents with pandemic potential
20. HIV co-infection in HTLV-1 carriers in Spain
21. Increased incidence and mortality from Listeria monocytogenes infection in Spain
22. COVID-19 mortality amongst the immunosuppresed
23. Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C
24. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients
25. Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy
26. Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection
27. Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response
28. Management of hepatitis C in HIV and/or HBV co-infected patients
29. No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients
30. Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
31. Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy
32. Third wave of COVID-19 in Madrid, Spain
33. Main differences between the first and second waves of COVID-19 in Madrid, Spain
34. Current epidemiological status of HIV-2 and HTLV-1 infection in Spain
35. Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España
36. The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies
37. Resistencia viral y barrera genética de atazanavir
38. Diagnóstico de las infecciones por subtipos no B del VIH-1 y por VIH-2
39. Resistencia a los inhibidores de la integrasa
40. Maraviroc: farmacocinética, interacciones y mecanismo de acción
41. Papel de tenofovir en la coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C
42. Resistencias en el virus de la hepatitis B
43. Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity
44. Recomendaciones españolas sobre el uso adecuado de enfuvirtida
45. Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): metodología y primeros resultados
46. Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C
47. Consejo reproductivo en parejas serodiscordantes para el virus de la inmunodeficiencia humana
48. HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates
49. Entrada del virus de la inmunodeficiencia humana en las células: mecanismos y posibilidades terapéuticas
50. Monitorización terapéutica y cociente inhibitorio de los fármacos antirretrovirales: ¿son aplicables a nuestra realidad?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.